| Human Precision-Cut Liver Slices as an ex Vivo Model to Study Idiosyncratic Drug-Induced Liver Injury M Hadi, IM Westra, V Starokozhko, S Dragovic, MT Merema, ... Chemical research in toxicology 26 (5), 710-720, 2013 | 68 | 2013 |
| Viability, function and morphological integrity of precision-cut liver slices during prolonged incubation: Effects of culture medium V Starokozhko, GB Abza, HC Maessen, MT Merema, F Kuper, ... Toxicology in Vitro 30 (1), 288-299, 2015 | 44 | 2015 |
| Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days V Starokozhko, S Vatakuti, B Schievink, MT Merema, A Asplund, ... Archives of toxicology 91, 2079-2092, 2017 | 43 | 2017 |
| Differentiation of human‐induced pluripotent stem cell under flow conditions to mature hepatocytes for liver tissue engineering V Starokozhko, M Hemmingsen, L Larsen, S Mohanty, M Merema, ... Journal of tissue engineering and regenerative medicine 12 (5), 1273-1284, 2018 | 40 | 2018 |
| Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury M Hadi, Y Chen, V Starokozhko, MT Merema, GMM Groothuis Chemical research in toxicology 25 (9), 1938-1947, 2012 | 38 | 2012 |
| Contribution of real‐world evidence in European medicines Agency's regulatory decision making E Bakker, K Plueschke, CJ Jonker, X Kurz, V Starokozhko, PGM Mol Clinical Pharmacology & Therapeutics 113 (1), 135-151, 2023 | 34 | 2023 |
| Judging the value of ‘liver-on-a-chip’devices for prediction of toxicity V Starokozhko, GMM Groothuis Expert opinion on drug metabolism & toxicology 13 (2), 125-128, 2017 | 31 | 2017 |
| Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap V Starokozhko, M Kallio, ÅK Howell, AM Salmi, G Andrew-Nielsen, ... Drug discovery today 26 (2), 283-288, 2021 | 30 | 2021 |
| Rat precision-cut liver slices predict drug-induced cholestatic injury V Starokozhko, R Greupink, P van de Broek, N Soliman, S Ghimire, ... Archives of toxicology 91, 3403-3413, 2017 | 21 | 2017 |
| Biomarker qualification at the European medicines agency: a review of biomarker qualification procedures from 2008 to 2020 E Bakker, NM Hendrikse, F Ehmann, DS Van der Meer, J Llinares Garcia, ... Clinical Pharmacology & Therapeutics 112 (1), 69-80, 2022 | 20 | 2022 |
| Challenges on the road to a multicellular bioartificial liver V Starokozhko, GMM Groothuis Journal of tissue engineering and regenerative medicine 12 (1), e227-e236, 2018 | 18 | 2018 |
| Translating academic drug discovery into clinical development: a survey of the awareness of regulatory support and requirements among stakeholders in Europe MJ Kallio, V Starokozhko, E Agricola, M Burggraf, A Heß, W Ballensiefen, ... Clinical Pharmacology & Therapeutics 113 (2), 349-359, 2023 | 8 | 2023 |
| Attention for sex in COVID-19 trials: a review of regulatory dossiers ST de Vries, V Starokozhko, IMM Schellens, L Wijnans, H Enzmann, ... BMJ Global Health 7 (3), e008173, 2022 | 7 | 2022 |
| Strategic recommendations from the STARS project to foster academic drug development V Starokozhko, A Heß, W Löbker, W Ballensiefen, E Agricola, B Ziegele, ... Nature Reviews Drug Discovery 22 (4), 251-252, 2023 | 4 | 2023 |
| How microtechnologies enable organs-on-a-chip E Verpoorte, PE Oomen, MD Skolimowski, P Mulder, PM van Midwoud, ... 2015 Transducers-2015 18th International Conference on Solid-State Sensors …, 2015 | 4 | 2015 |
| Erratum to: Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days V Starokozhko, S Vatakuti, B Schievink, MT Merema, A Asplund, ... Archives of toxicology 91 (7), 2711, 2017 | 3 | 2017 |
| Disruption of vitamin A homeostasis by the biocide tetrakis (hydroxymethyl) phosphonium sulphate in pregnant rabbits N Estrada‐Ortiz, V Starokozhko, H van Steenwijk, C van der Heide, ... Journal of Applied Toxicology 42 (12), 1921-1936, 2022 | 1 | 2022 |
| The European Innovation Network as a hub for medicines innovation in Europe E Agricola, C Auriche-Benichou, H Baiao, O Blanquie, T Bodea, T Boráň, ... Nature Reviews Drug Discovery, 2024 | | 2024 |
| Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020 E Bakker, V Starokozhko, JWM Kraaijvanger, HJL Heerspink, PGM Mol Clinical and translational science 16 (11), 2394-2412, 2023 | | 2023 |
| Safety‐Related Drug Label Changes Following Large Post‐Marketing Cardiometabolic Trials: A Review of European Public Assessment Reports V Starokozhko, F Tarrahi, PJWS Vrijlandt, PGM Mol Clinical Pharmacology & Therapeutics 113 (4), 859-866, 2023 | | 2023 |
